Development and Verification of the PAM50-based Prosigna Breast Cancer Gene Signature Assay

BMC Medical Genomics - United Kingdom
doi 10.1186/s12920-015-0129-6
Full Text
Abstract

Available in full text

Categories
Genetics
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Prosigna Gene Expression Assay and Responsiveness to Adjuvant Cyclophosphamide-Based Chemotherapy in Premenopausal High-Risk Patients With Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2018English

Association of High Obesity With PAM50 Breast Cancer Intrinsic Subtypes and Gene Expression

BMC Cancer
Cancer ResearchOncologyGenetics
2015English

Immortalization-Associated Gene Signature in Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2005English

RNA Chimeras as a Gene Signature of Breast Cancer

2014English

Gene Signature: A Guideline for Hormonal Therapy in Breast Cancer

Journal of Steroids & Hormonal Science
2015English

The Genomic Signature of Breast Cancer Prevention

English

The Predictive Value of the 70-Gene Signature for Adjuvant Chemotherapy in Early Breast Cancer

Breast Cancer Research and Treatment
Cancer ResearchOncology
2010English

A miRNA-based Signature Predicts Development of Disease Recurrence in HER2 Positive Breast Cancer After Adjuvant Trastuzumab-Based Treatment

Scientific Reports
Multidisciplinary
2016English

Development and Validation of an Immune-Related Gene Pairs Signature in Colorectal Cancer

OncoImmunology
OncologyAllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy